Abstract 3448: Fibroblast growth factor receptor is expressed as a constitutively active receptor tyrosine kinase in chronic lymphocytic leukemia B cells and exists in an active complex with Axl: Dual targeting in CLL

Author(s):  
Sutapa Sinha ◽  
Justin Boyson ◽  
Charla Secreto ◽  
Steven L. Warner ◽  
Neil E. Kay ◽  
...  
2007 ◽  
Vol 17 (17) ◽  
pp. 4812-4818 ◽  
Author(s):  
Naparat Kammasud ◽  
Chantana Boonyarat ◽  
Satoshi Tsunoda ◽  
Hiroaki Sakurai ◽  
Ikuo Saiki ◽  
...  

Author(s):  
Melanie B. Laederich ◽  
William A. Horton

Mutations that exaggerate signalling of the receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) give rise to achondroplasia, the most common form of dwarfism in humans. Here we review the clinical features, genetic aspects and molecular pathogenesis of achondroplasia and examine several therapeutic strategies designed to target the mutant receptor or its signalling pathways, including the use of kinase inhibitors, blocking antibodies, physiologic antagonists, RNAi and chaperone inhibitors. We conclude by discussing the challenges of treating growth plate disorders in children.


Sign in / Sign up

Export Citation Format

Share Document